|
|
|
|
| LEADER |
02512cam a22005417a 4500 |
| 001 |
BIBLO-45527 |
| 003 |
AR-BaUEN |
| 005 |
20201111150513.0 |
| 008 |
111123s2010 xxu||||f |||| 00| 0|eng|d |
| 040 |
|
|
|a AR-BaUEN
|b spa
|c AR-BaUEN
|
| 020 |
|
|
|a 9781420082210
|
| 044 |
|
|
|a xxu
|
| 080 |
|
|
|a 641.1
|b P273
|
| 245 |
0 |
0 |
|a Handbook of nutraceuticals :
|b ingredients, formulations and applications
|
| 260 |
|
|
|a Boca Raton :
|b CRC Press,
|c 2010
|
| 300 |
|
|
|a v.
|
| 505 |
0 |
0 |
|t Foreword
|
| 505 |
0 |
0 |
|t Preface
|
| 505 |
0 |
0 |
|t Contributors
|
| 505 |
0 |
0 |
|g Chapter 1
|t Nutraceuticals of Antiquity
|
| 505 |
0 |
0 |
|g Chapter 2
|t Nutraceuticals: Definitions, Formulations, and Challenges
|
| 505 |
0 |
0 |
|g Chapter 3
|t Potential Nutraceutical Ingredients from Plant Origin
|
| 505 |
0 |
0 |
|g Chapter 4
|t Nutraceuticals with Animal Origin
|
| 505 |
0 |
0 |
|g Chapter 5
|t Nutraceuticals with Mineral Origin
|
| 505 |
0 |
0 |
|g Chapter 6
|t Physiochemical Characterization of Nutraceuticals
|
| 505 |
0 |
0 |
|g Chapter 7
|t Development of Techniques for Analysis of Nutraceuticals with Specific Reference to Glucosamine and Coenzyme Q₁₀
|
| 505 |
0 |
0 |
|g Chapter 8
|t Pharmacological Characterization Nutraceuticals
|
| 505 |
0 |
0 |
|g Chapter 9
|t Biopharmaceutical and Pharmacokinetic Characterization
|
| 505 |
0 |
0 |
|g Chapter 10
|t Regulatory Considerations for Dietary Supplements and Functional cGMPs
|
| 505 |
0 |
0 |
|g Chapter 11
|t Nutraceuticals for the Cardiovascular System
|
| 505 |
0 |
0 |
|g Chapter 12
|t Nutraceuticals in Diabetes Management
|
| 505 |
0 |
0 |
|g Chapter 13
|t Curcumin: A Versatile Nutraceutical and an Inhibitor of Complement
|
| 505 |
0 |
0 |
|g Chapter 14
|t Probiotics and Prebiotics as Nutraceuticals
|
| 505 |
0 |
0 |
|g Chapter 15
|t Nutraceuticals and Weight Management
|
| 505 |
0 |
0 |
|g Chapter 16
|t Nutraceuticals for Bone and Joint Diseases
|
| 505 |
0 |
0 |
|g Chapter 17
|t Nutraceuticals for Skin Health
|
| 505 |
0 |
0 |
|g Chapter 18
|t Tranquilizing Medicinal Plants: Their CNS Effects and Active Constituents—Our Experience
|
| 505 |
0 |
0 |
|g Chapter 19
|t Dietary Food
|
| 505 |
0 |
0 |
|g Chapter 20
|t Antiviral Nutraceuticals from Pomegranate (Punica granatum) Juice
|
| 505 |
0 |
0 |
|g Chapter 21
|t Herbal Remedy: Safe or Not Safe? How to Use Them?
|
| 505 |
0 |
0 |
|g Chapter 22
|t Nutraceuticals: Reflections
|
| 505 |
0 |
0 |
|t Index
|
| 653 |
1 |
0 |
|a NUTRACEUTICOS
|
| 653 |
1 |
0 |
|a SUPLEMENTOS DIETARIOS
|
| 653 |
1 |
0 |
|a ALIMENTOS FUNCIONALES
|
| 700 |
1 |
|
|a Pathak, Yashwant
|
| 962 |
|
|
|a info:eu-repo/semantics/book
|a info:ar-repo/semantics/libro
|b info:eu-repo/semantics/publishedVersion
|
| 999 |
|
|
|c 35899
|